No abstract available
MeSH terms
-
Angiogenesis Inhibitors / therapeutic use*
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Humans
-
Infant, Newborn
-
Infant, Premature
-
Intravitreal Injections
-
Laser Therapy* / adverse effects
-
Recurrence
-
Retina / pathology
-
Retinopathy of Prematurity / drug therapy*
-
Retinopathy of Prematurity / therapy
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab